Growing up in Italy, I found my happy place with science. Even when dealing with a challenging home life, science offered an escape. But I didn’t get my start in research until later in life.  

Now, as a principal investigator with my own lab at MD Anderson, I work with a talented group of researchers focused on myelodysplastic syndrome, specifically how it develops and becomes resistant to treatment. My lab is my life...

Since the discovery of KRAS gene mutations in 1983, researchers have worked to develop new therapies that target this protein when treating cancer. Unfortunately, KRAS mutations have long been considered impossible to treat with drugs, but MD Anderson researchers have made recent breakthroughs in developing targeted therapies with promising results.

Shubham Pant, M.D., associate professor of Investigational Cancer Therapeutics...